Veritas In Silico

Veritas In Silico EBIT

The EBIT of Veritas In Silico (130A.T) as of Oct 27, 2026 is -396.75 M JPY. In the previous year, EBIT was -212.85 M JPY — a change of 86.40% (lower).

EBIT

-396.75 MJPY

YoY

86.40%

Last updated:

In 2025, Veritas In Silico's EBIT was -396.75 M JPY, a 86.40% increase from the -212.85 M JPY EBIT recorded in the previous year.

The Veritas In Silico EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2021
-235.51 M JPY
Jan 1, 2022
-138.91 M JPY
Jan 1, 2023
37.62 M JPY
Jan 1, 2024
-212.85 M JPY
Jan 1, 2025
-396.75 M JPY
Jan 1, 2026 (e)
0.00 JPY
The Veritas In Silico EBIT history
YEAREBITYoY
est0.00JPY-100.00%
-396.75 MJPY+86.40%
-212.85 MJPY-665.74%
37.62 MJPY-127.08%
-138.91 MJPY-41.02%
-235.51 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Veritas In Silico Revenue

Veritas In Silico Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
54.43 M JPY
-235.51 M JPY
-232.32 M JPY
Jan 1, 2022
178.80 M JPY
-138.91 M JPY
-141.38 M JPY
Jan 1, 2023
360.36 M JPY
37.62 M JPY
33.05 M JPY
Jan 1, 2024
185.29 M JPY
-212.85 M JPY
-236.44 M JPY
Jan 1, 2025
91.14 M JPY
-396.75 M JPY
-425.67 M JPY
Jan 1, 2026 (e)
0.00 JPY
0.00 JPY
0.00 JPY

Veritas In Silico Margins

Veritas In Silico stock margins

The Veritas In Silico margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Veritas In Silico. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Veritas In Silico.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
0.00 %
-432.68 %
-426.82 %
Jan 1, 2022
0.00 %
-77.69 %
-79.07 %
Jan 1, 2023
0.00 %
10.44 %
9.17 %
Jan 1, 2024
0.00 %
-114.87 %
-127.61 %
Jan 1, 2025
0.00 %
-435.32 %
-467.05 %
Jan 1, 2026 (e)
0.00 %
0.00 %
0.00 %

Veritas In Silico Stock analysis

What does Veritas In Silico do? Veritas In Silico Inc generates revenue through its ibVIS platform, which provides small molecule drug discovery services targeting mRNA. The company collaborates with pharmaceutical companies on joint drug discovery research to develop mRNA-targeted small molecule drugs. Its primary customers are pharmaceutical companies seeking innovative drug discovery solutions. The business focuses on integrating digital technology, including in silico RNA structural analysis, into the pharmaceutical discovery process. The company's core product, the ibVIS platform, combines in silico RNA structural analysis with drug discovery technology to accelerate the development of small molecule drugs targeting mRNA. This platform is offered as a service to pharmaceutical partners, enabling them to leverage advanced digital tools for more efficient drug discovery. The revenue model is based on contractual agreements with pharmaceutical firms for joint research projects. Veritas In Silico Inc's business model centers on providing specialized technology services to the pharmaceutical industry. The company does not sell physical products but offers its platform as a service for drug discovery. Its target market consists of pharmaceutical companies interested in mRNA-targeted therapies, which represent a growing segment in pharmaceutical research and development. Veritas In Silico is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Veritas In Silico's EBIT

Veritas In Silico's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Veritas In Silico's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Veritas In Silico's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Veritas In Silico’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Veritas In Silico stock

EBIT of Veritas In Silico is -396.75 M JPY in 2025.

EBIT of Veritas In Silico changed from -212.85 M JPY to -396.75 M JPY, representing a 86.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Veritas In Silico since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Veritas In Silico historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Veritas In Silico

All Key Metrics — Veritas In Silico